Garety, Philippa A. https://orcid.org/0000-0002-5637-1340
Edwards, Clementine J.
Jafari, Hassan https://orcid.org/0000-0002-4541-6419
Emsley, Richard
Huckvale, Mark https://orcid.org/0000-0002-4503-5552
Rus-Calafell, Mar https://orcid.org/0000-0003-2293-3875
Fornells-Ambrojo, Miriam
Gumley, Andrew
Haddock, Gillian https://orcid.org/0000-0001-6234-5774
Bucci, Sandra
McLeod, Hamish J. https://orcid.org/0000-0002-4225-1815
McDonnell, Jeffrey
Clancy, Moya
Fitzsimmons, Michael
Ball, Hannah https://orcid.org/0000-0002-1178-5080
Montague, Alice
Xanidis, Nikos
Hardy, Amy https://orcid.org/0000-0002-6044-6093
Craig, Thomas K. J.
Ward, Thomas https://orcid.org/0000-0002-7608-5755
Funding for this research was provided by:
Wellcome Trust (215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z, 215471/Z/19/Z)
Article History
Received: 10 April 2024
Accepted: 15 August 2024
First Online: 28 October 2024
Competing interests
: M.H. is a shareholder of Avatar Therapy Ltd. T.K.J.C. and P.A.G. are unpaid scientific advisers to Avatar Therapy Ltd. S.B. is Director and shareholder of CareLoop Health Ltd, which develops and markets digital therapeutics for schizophrenia and a digital screening app for postnatal depression. The other authors declare no competing interests.